z-logo
open-access-imgOpen Access
Guidance on the environmental risk assessment of genetically modified animals
Publication year - 2013
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2013.3200
Subject(s) - directive , risk assessment , european union , hazard , genetically modified organism , risk analysis (engineering) , environmental risk assessment , risk management , fish <actinopterygii> , genetically modified food , business , environmental planning , environmental resource management , biology , computer science , geography , ecology , environmental science , fishery , international trade , biochemistry , computer security , finance , gene , programming language
This document provides guidance for the environmental risk assessment (ERA) of living genetically modified (GM) animals, namely fish, insects and mammals and birds, to be placed on the European Union (EU) market in accordance with Regulation (EC) No 1829/2003 or Directive 2001/18/EC. It provides guidance for assessing potential effects of GM animals on animal and human health and the environment and the rationales for data requirements for a comprehensive ERA. The ERA should be carried out on a case‐by‐case basis, following a step‐by‐step assessment approach. This document describes the six sequential steps for the ERA of GM animals, as indicated in Directive 2001/18/EC: (1) problem formulation including hazard and exposure identification; (2) hazard characterisation; (3) exposure characterisation; (4) risk characterisation; (5) risk management strategies; and (6) an overall risk evaluation. The Scientific Panel on Genetically Modified Organisms of the European Food Safety Authority follows Annex II of Directive 2001/18/EC, considering specific areas of risk to be addressed by applicants and risk assessors during the ERA of GM fish, GM insects and GM mammals and birds. Each specific area of risk is considered in a structured and systematic way following the aforementioned six steps. In addition, this Guidance Document describes several generic cross‐cutting considerations (e.g. choice of comparators, use of non‐GM surrogates, experimental design and statistics, long‐term effects, uncertainty analysis) that need to be accounted for throughout the whole ERA.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here